Search Results - "Somi, Mohammadhossein"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Non-invasive serum fibrosis markers: A study in chronic hepatitis by Abdollahi, Mohammadreza, Pouri, Aliasghar, Ghojazadeh, Morteza, Estakhri, Rasoul, Somi, Mohammadhossein

    Published in Bioimpacts (01-01-2015)
    “…Role of noninvasive fibrosis markers as prognostication factors of the presence or absence of significant fibrosis on liver biopsy of patients with chronic…”
    Get full text
    Journal Article
  3. 3

    Prevalence of Hepatitis B genotypes worldwide and in Iran: A meta-analysis by Baghernezhad, Kosar, Somi, Mohammadhossein, Rahmanpour, Dara, Ghojazadeh, Morteza, Rsotamizadeh, Leila, Shirmohammadi, Masood, Salehi-Pourmehr, Hanieh, Naseri, Amirreza

    “…Background. Chronic hepatitis B is associated with different long-term outcomes in various regions. One of the critical predictors of clinical outcomes is the…”
    Get full text
    Journal Article
  4. 4

    Association between food insecurity and metabolic syndrome in North West of Iran: Azar Cohort study by Faramarzi, Elnaz, Somi, Mohammadhossein, Ostadrahimi, Alireza, Dastgiri, Saaed, Ghayour Nahand, Mousa, Asgari Jafarabadi, Mohammad, Sanaie, Sarvin

    “…Introduction: Nowadays, prevalence of metabolic syndrome (MetS) is increasing in the world. There are inconsistence findings about the relationship between…”
    Get full text
    Journal Article
  5. 5

    Red blood cell distribution width: a determinant of hospital mortality in pancreatitis by Moharamzadeh, Payman, Shahsavari Nia, Kavous, Somi, Mohammadhossein, Pouraghaei, Mahboub, Fadaeihaghi, Akbar, Rahmani, Farzad

    Published in Journal of emergency practice and trauma (01-06-2018)
    “…Objective: In recent years, there has been a great attention concerning red blood cell distribution width (RDW) in clinical decisions as well as determining…”
    Get full text
    Journal Article
  6. 6

    Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations? by Abdollahi, Mohammadreza, Ekrami, Neda Khalilian, Ghojazadeh, Morteza, Boezen, H Marike, Somi, Mohammadhossein, Alizadeh, Behrooz Z

    Published in World journal of gastroenterology : WJG (14-10-2020)
    “…The standard management of autoimmune hepatitis (AIH) is based on corticosteroids, alone or in combination with azathioprine. Second-line treatments are needed…”
    Get full text
    Journal Article
  7. 7

    Prevalence and Predicting Risk Factors of Polypharmacy in Azar Cohort Population by Gharekhani, Afshin, Somi, Mohammadhossein, Ostadrahimi, Alireza, Hatefi, Ayda, Haji Kamanaj, Arash, Hassannezhad, Sina, Faramarzi, Elnaz

    “…Background: As polypharmacy has some medically negative impacts, it has become a challenging issue for public health and affected people. Therefore, we decided…”
    Get full text
    Journal Article
  8. 8

    Survival of familial adenomatous polyposis coexistence colorectal cancer in Iran by Mirinezhad, Seyed, Moaddab, Seyed, Bonyadi, Mortaza, Shirmohammadi, Masoud, Eftekharsadat, Amir, Somi, Mohammad

    “…Context: Familial adenomatous polyposis (FAP) is an autosomal dominant disorder. Colorectal cancer (CRC) has been implicated as the most common cause of death…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11